| First Author | Ramírez S | Year | 2022 |
| Journal | Cell Metab | Volume | 34 |
| Issue | 2 | Pages | 269-284.e9 |
| PubMed ID | 35108514 | Mgi Jnum | J:321590 |
| Mgi Id | MGI:6875526 | Doi | 10.1016/j.cmet.2021.12.023 |
| Citation | Ramirez S, et al. (2022) Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metab 34(2):269-284.e9 |
| abstractText | Obesity and type 2 diabetes are associated with cognitive dysfunction. Because the hypothalamus is implicated in energy balance control and memory disorders, we hypothesized that specific neurons in this brain region are at the interface of metabolism and cognition. Acute obesogenic diet administration in mice impaired recognition memory due to defective production of the neurosteroid precursor pregnenolone in the hypothalamus. Genetic interference with pregnenolone synthesis by Star deletion in hypothalamic POMC, but not AgRP neurons, deteriorated recognition memory independently of metabolic disturbances. Our data suggest that pregnenolone's effects on cognitive function were mediated via an autocrine mechanism on POMC neurons, influencing hippocampal long-term potentiation. The relevance of central pregnenolone on cognition was also confirmed in metabolically unhealthy patients with obesity. Our data reveal an unsuspected role for POMC neuron-derived neurosteroids in cognition. These results provide the basis for a framework to investigate new facets of POMC neuron biology with implications for cognitive disorders. |
